Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00600470
Other study ID # R01MH063272
Secondary ID R01MH063272DSIR
Status Completed
Phase Phase 1/Phase 2
First received January 14, 2008
Last updated May 29, 2015
Start date September 2000
Est. completion date August 2013

Study information

Verified date May 2015
Source University of Pittsburgh
Contact n/a
Is FDA regulated No
Health authority United States: Federal Government
Study type Interventional

Clinical Trial Summary

This study will evaluate the effectiveness of a doctor-office collaborative care approach in treating children with disruptive behavior problems in the pediatric primary care setting.


Description:

Disruptive behavior problems (DBP) involve a behavioral tendency of children and adolescents to continually disregard basic social rules and the rights of others. Symptoms of DBP include problematic aggression, antisocial tendencies, serious defiance of rules, and temper tantrums. Children or adolescents with DBP display this type of behavior at school, home, or other social situations, often affecting family life, academic performance, and relations with others. The causes of DBP are believed to be both environmental and biological. Children most at risk for DBP are those who have low birth weight, attention deficit hyperactivity disorder (ADHD), or a history of abuse or neglect. Behavioral therapy that targets parent and child skills has shown to be the most effective treatment for DBP. This study will evaluate the effectiveness of a doctor-office collaborative care (DOCC) approach in treating children with DBP in the pediatric primary care setting. The study is a continuation and extension of the parent study, Services for Kids in Primary Care (SKIP).

Participants in this single blind study will be randomly assigned to one of two treatment groups: doctor-office collaborative care (DOCC) or treatment as usual (TAU). Treatment will take place at one of eight participating primary care practices, each randomly assigned to either DOCC or TAU. All participants will undergo an initial assessment that will include a clinical evaluation with the care manager and research questionnaires. The families participating in the practices assigned to DOCC will receive cognitive behavioral therapy (CBT), parent management training (PMT), and ADHD management training. Participants will also complete ongoing behavioral questionnaires. There will be on average 12 DOCC sessions, lasting between 30 and 90 minutes, held in the primary care office. The sessions will occur over a 3- to 6-month period. The families participating in the practices assigned to TAU will receive a full review of initial assessment findings and specific recommendations for services in the community that would meet the clinical needs of the child participant. The parent/guardian of the child will also be provided psychoeducational resources via Web sites, literature, or reference materials. Lastly, participants in TAU will receive a follow-up call between 2 and 4 weeks after the initial assessment to assist with finding community programs or additional resource identification. All participants in both groups will undergo follow-up assessments at Months 6, 12, 18, 24, and 30 after the initial assessment. Each assessment will last 2 to 3 hours and will include self-report and interview questionnaires.


Recruitment information / eligibility

Status Completed
Enrollment 858
Est. completion date August 2013
Est. primary completion date August 2013
Accepts healthy volunteers No
Gender Both
Age group 5 Years to 12 Years
Eligibility Inclusion Criteria:

- Score of 75% on externalizing scale of PSC-17: score less than or equal to 6

- Parent/guardian is concerned about the child's mental health

- At least one parent/guardian who resides with the child is willing to participate in services and has signed an informed consent giving permission for the child to participate

Exclusion Criteria:

- Child is currently prescribed and taking any of the following medications: SSRI, neuroleptics, antidepressants.

- Emergent psychiatric conditions that require additional treatments (e.g., eating disorder/anorexia nervosa, substance dependence, PTSD-active phase, OCD, PDD/Autism/Aspergers)

- Child has current suicidal or homicidal ideation with intent and a plan

- Participation in ongoing outpatient services and plans to continue

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms

  • Attention Deficit and Disruptive Behavior Disorders
  • Attention Deficit Disorder with Hyperactivity
  • Mental Disorders

Intervention

Behavioral:
Doctor-office collaborative care (DOCC) management
DOCC is an evidence-based psychosocial treatment approach that incorporates (1) adaptation of an evidence-based collaborative care approach using the chronic care model and participatory management theory to enhance training, implementation, and sustainability; (2) revised protocol content that includes medication management for ADHD, brief anxiety management, and attention to parental/partner dysfunction; (3) technological developments to facilitate screening/assessment, monitoring, and communication; and (4) an improved methodology that includes new samples, measures, and settings.
Treatment as usual (TAU)
TAU involves routine care: psychoeducation and referral to outside providers.

Locations

Country Name City State
United States Western Psychiatric Institute and Clinic (WPIC) Pittsburgh Pennsylvania

Sponsors (2)

Lead Sponsor Collaborator
University of Pittsburgh National Institute of Mental Health (NIMH)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Vanderbilt Parent ADHD Rating Scale; Child Health and Illness Profile; Pediatric Quality of Life Inventory; Individualized Goal Attainment Rating Measured at baseline and at Months 6, 12, 18, 24, and 30 No
Secondary Parenting Stress Index; Brief Symptom Inventory; Alabama Parenting Questionnaire; Services Assessment for Children and Adolescents Measured at baseline and at Months 6, 12, 18, 24, and 30 No
See also
  Status Clinical Trial Phase
Completed NCT03698240 - Mindfulness-based Program for Children With Disruptive Behavior Disorder N/A
Completed NCT02766101 - Manville Moves: an Exercise Intervention for Behavioral Regulation Among Children With Behavioral Health Challenges N/A
Completed NCT02897570 - Metabolic and Neurofunctional Responses to Breakfasts N/A
Recruiting NCT04946253 - SKIP for PA Study: Team and Leadership Level Implementation Support for Collaborative Care N/A
Completed NCT00402857 - Parent Training to Promote Early Identification and Treatment of Childhood Behavioral Disorders Phase 3
Completed NCT03597789 - Tantrum Tamers 2.0: The Role of Emotion N/A
Recruiting NCT01350986 - Guided Self-Help for Parents of Children With Externalizing Problem Behavior N/A
Completed NCT00163865 - A Pilot Study of Boredom in a Community Sample of Adolescents and a Clinical Sample of Adolescents N/A
Completed NCT02893852 - Effects of CO-OP Approach on Activity and Participation of Brazilian Children With Developmental Coordination Disorder N/A
Terminated NCT02094612 - Effectiveness of the Quotient® ADHD Assessment in a System of Care N/A
Completed NCT01940978 - A Study of Combination Therapy in Children With ADHD Phase 4
Completed NCT02305134 - Tipepidine in Children With Attention Deficit/Hyperactivity Disorder (AD/HD): a Double-blind, Placebo-controlled Trial Phase 1/Phase 2
Completed NCT03927612 - Virtual Reality to Improve Social Perspective Taking N/A
Completed NCT03976570 - The Effect of Occupational Therapy on Subthreshold Attention Deficit Hyperactivity Disorder N/A
Recruiting NCT04238403 - Peer Professionals to Increase Capacity to Treat ADHD N/A
Completed NCT00218114 - Divalproex Sodium (Depakote) for Explosive Tempers in Adolescents and Adults Phase 3
Completed NCT01919073 - Efficacy of a Brief Behavioral Intervention to Treat ADHD and Disruptive Behaviors In Preschoolers N/A
Completed NCT00236444 - A Study of the Efficacy and Safety of Risperidone in the Prevention of Relapse in Children and Adolescents With Conduct and Other Disruptive Behavior Disorders Phase 3
Completed NCT00001233 - Study of Children at Risk for Disruptive Behavior Disorders N/A
Recruiting NCT05683756 - A Sleep Focused Parenting Intervention for Preschool Aged Children at Risk for ADHD N/A